These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1674259)

  • 21. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
    Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
    Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of nasal carriage of Staphylococcus aureus and susceptibility of isolates to methicillin and mupirocin among healthcare workers in an Iranian Hospital.
    Rahbar M; Yaghoobi M; Kia-Darbandsari B
    Infect Control Hosp Epidemiol; 2006 Mar; 27(3):323-5. PubMed ID: 16532427
    [No Abstract]   [Full Text] [Related]  

  • 23. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel].
    Dmitrieva NV; Solodovnik FI; Petukhova IN
    Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacitracin versus mupirocin for Staphylococcus aureus nasal colonization.
    Soto NE; Vaghjimal A; Stahl-Avicolli A; Protic JR; Lutwick LI; Chapnick EK
    Infect Control Hosp Epidemiol; 1999 May; 20(5):351-3. PubMed ID: 10349956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
    Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
    J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of Staphylococcus aureus in hemodialysis patients.
    Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W
    ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of mupirocin calcium ointment for eliminating nasal carriage of Staphylococcus aureus among hospital personnel.
    Fernandez C; Gaspar C; Torrellas A; Vindel A; Saez-Nieto JA; Cruzet F; Aguilar L
    J Antimicrob Chemother; 1995 Mar; 35(3):399-408. PubMed ID: 7782256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution.
    Boyce JM
    Infect Control Hosp Epidemiol; 1996 Dec; 17(12):775-9. PubMed ID: 8985762
    [No Abstract]   [Full Text] [Related]  

  • 29. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection.
    Wenzel RP; Perl TM
    J Hosp Infect; 1995 Sep; 31(1):13-24. PubMed ID: 7499817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
    Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
    Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
    Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
    J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.
    Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR
    Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus.
    Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal carriage of gentamicin and methicillin resistant Staphylococcus aureus treated with topical pseudomonic acid.
    Dacre JE; Emmerson AM; Jenner EA
    Lancet; 1983 Oct; 2(8357):1036. PubMed ID: 6138588
    [No Abstract]   [Full Text] [Related]  

  • 35. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization.
    Peña C; Fernández-Sabe N; Domínguez MA; Pujol M; Martinez-Castelao A; Ayats J; Gudiol F; Ariza J
    J Hosp Infect; 2004 Sep; 58(1):20-7. PubMed ID: 15350709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of mupirocin on nasal carriage of Staphylococcus aureus.
    Bulanda M; Gruszka M; Heczko B
    J Hosp Infect; 1989 Aug; 14(2):117-24. PubMed ID: 2572628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-cesarean Staphylococcus aureus nasal screening and decolonization: a prospective randomized controlled trial.
    Shrem G; Egozi T; Naeh A; Hallak M; Walfisch A
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3906-11. PubMed ID: 26857727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study.
    Wertheim HF; Vos MC; Ott A; Voss A; Kluytmans JA; Vandenbroucke-Grauls CM; Meester MH; van Keulen PH; Verbrugh HA
    Ann Intern Med; 2004 Mar; 140(6):419-25. PubMed ID: 15023707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reclassification of Staphylococcus aureus nasal carriage types.
    van Belkum A; Verkaik NJ; de Vogel CP; Boelens HA; Verveer J; Nouwen JL; Verbrugh HA; Wertheim HF
    J Infect Dis; 2009 Jun; 199(12):1820-6. PubMed ID: 19419332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage.
    Perl TM; Golub JE
    Ann Pharmacother; 1998 Jan; 32(1):S7-16. PubMed ID: 9475834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.